© 2019 HealthDay. All rights reserved.
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
TUESDAY, Jan. 29, 2019 -- The U.S. Preventive Services Task Force (USPSTF) has reaffirmed the recommendation for use of ocular prophylaxis for gonococcal ophthalmia neonatorum. This recommendation forms the basis of a final recommendation statement published online Jan. 29 in the Journal of the American Medical Association.
FRIDAY, Jan. 25, 2019 -- Americans were less likely to use eye care in 2014 versus 2008 but had decreased difficulty affording eyeglasses from 2014 onward, according to a study published online Jan. 24 in JAMA Ophthalmology.
Abstract/Full Text (subscription or payment may be required)
FRIDAY, Jan. 25, 2019 -- In a report published in the January issue of Value in Health, an ISPOR--The Professional Society for Health Economics and Outcomes Research working group indicates the lack of good practices in three areas of health technology assessment (HTA).
Abstract/Full Text (subscription or payment may be required)
THURSDAY, Jan. 17, 2019 -- Due to the federal government shutdown, the U.S. Food and Drug Administration has only about five weeks of funding left to review new drug applications, according to Commissioner Scott Gottlieb, M.D.
WEDNESDAY, Jan. 16, 2019 -- Adoption of advanced health information technology (HIT) capabilities is inconsistent across health care systems, with electronic health record (EHR) standardization being the strongest predictor of advanced capabilities, according to a study published in the January issue of the American Journal of Managed Care.
TUESDAY, Jan. 15, 2019 -- The influence of heritability and environmental factors has been identified for a large number of phenotypes, according to a study published online Jan. 14 in Nature Genetics.
Abstract/Full Text (subscription or payment may be required)
TUESDAY, Jan. 15, 2019 -- Ethical principles are discussed in an updated Ethics Manual, issued by the American College of Physicians (ACP) and published as a supplement to the Jan. 15 issue of the Annals of Internal Medicine.
FRIDAY, Jan. 11, 2019 -- For Taiwanese patients with type 2 diabetes and dyslipidemia, statin therapy is associated with a reduced risk for diabetic retinopathy, according to a study published online Jan. 10 in JAMA Ophthalmology.
Abstract/Full Text (subscription or payment may be required)
FRIDAY, Jan. 11, 2019 -- The difference in health spending between the United States and other countries is still explained by health care prices, according to a study published in the January issue of Health Affairs.
Abstract/Full Text (subscription or payment may be required)
THURSDAY, Jan. 10, 2019 -- The phenomenon of private equity acquisition of physician practices is discussed in an Ideas and Opinions piece published online Jan. 8 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
WEDNESDAY, Jan. 9, 2019 -- Many U.S. female health care workers, particularly women of color, live in poverty and lack health insurance, according to a study published online Dec. 20 in the American Journal of Public Health.
Abstract/Full Text (subscription or payment may be required)
WEDNESDAY, Jan. 9, 2019 -- The costs of oral and injectable brand-name drugs increased from 2008 to 2016, with most of the increase due to existing drugs, while new drugs accounted for cost increases in specialty and generic drugs, according to a study published in the January issue of Health Affairs.
Abstract/Full Text (subscription or payment may be required)
TUESDAY, Jan. 8, 2019 -- From 1997 through 2016, there was an increase in medical marketing, especially direct-to-consumer (DTC) advertising, according to research published in the Jan. 1/8 issue of the Journal of the American Medical Association.
TUESDAY, Jan. 8, 2019 -- The overall cancer death rate decreased continuously by 27 percent from 1991 to 2016, according to a report published online Jan. 8 in CA: A Cancer Journal for Clinicians.
TUESDAY, Jan. 8, 2019 -- Eliminating the Affordable Care Act's individual mandate penalty is unlikely to destabilize the individual market in California but could roll back coverage gains, according to a study published in the January issue of Health Affairs.
Abstract/Full Text (subscription or payment may be required)
Posted: February 2019